Skip to main content

Search form

Medicines for Malaria Venture

Developing antimalarials to save lives

  • Research & Development
    • MMV-supported projects
    • R&D areas of work
      • Next-generation medicines
      • Products for key populations
    • Working with regulators
    • Information for scientists
      • Malaria online course
      • Global health compound design webinars
      • Call for proposals
      • TPPs & TCPs
      • Learning resources for scientists
    • Project of the year award
    • Computational chemistry
    • R&D challenges
  • Access
    • Products & projects
    • Product availability maps
    • Areas of work
      • Supporting introduction
      • Enhancing reach
      • Informing R&D
      • Gathering market intelligence
    • Tool Kits
      • Injectable Artesunate tool kit
      • Artesunate rectal capsules tool kit
      • Seasonal Malaria Chemoprevention tool kit
    • Access challenges
  • Partnering
    • The PDP model
    • Our partner network
    • Our donors
      • Current donors
      • Past donors
    • Donate to MMV
    • Socially responsible agreements
    • Our clinical centre partners
  • Our impact
    • Milestones
    • Real life stories
    • Better medicines for children
    • Gender equity
    • Global health security
      • Malaria and COVID-19
      • Tackling antimicrobial resistance
  • About us
    • What we do
      • An overview of our work
      • Our strategic focus
      • Our history
    • People & governance
      • Staff bios
      • Staff interviews
      • Board of Directors
      • MMV North America Board
      • Expert Scientific Advisory Committee
      • Access & Product Management Advisory Committee
      • Global Safety Board
    • Work with us
      • Jobs
      • RFPs/RFIs
    • Policies
    • Diversity at MMV
    • Funding and expenditure
    • FAQs
    • Contact us
  • Malaria & medicines
    • Definitions and symptoms
    • Five species
    • Parasite lifecycle
    • Malaria facts & figures
    • Malaria treatment
    • History of antimalarials
  • Newsroom
    • News & Press Releases
    • Audio
      • Media interviews
      • Speaking of Malaria podcast
    • Films
    • Infographics
    • Interviews
    • Image slideshows
    • Publications
    • Events
  • MMV Open
    • Malaria Libre
      • About Malaria Libre
      • Participate in Malaria Libre
      • Malaria Libre data repository
    • MMVSola
      • About MMVSola
    • Pandemic Response Box
      • About the Pandemic Response Box
      • Request the Pandemic Response Box
      • Supporting information
      • Terms & conditions
    • COVID Box
      • About the COVID Box
      • Supporting information
      • COVID Box terms and conditions
    • Archived projects
      • Pathogen Box
      • Malaria Box
    • MMV Open Team
    • Contact us
  • Home
  • Newsroom

Newsroom

News

MMV announces the start of ARCTIC, a feasibility study of a new Plasmodium vivax malaria treatment protocol

22 Jul 2022
News story

MMV echoes Fight the Fakes Alliance’s call for Global Fund Replenishment to prevent increase in falsified medicines

14 Jul 2022
News story

MMV awards Project of the Year 2021 to GSK for the discovery of GSK484

12 Jul 2022
News story
View all news

Media enquiries

Elizabeth Poll,
Director, Communications
+41 (0) 79 907 5992
polle [at] mmv.org

Media resources

MMV logo
About MMV
MMV at a Glance
Annual report 2021

Newsroom

Publications

Opinion: Preventing malaria in pregnancy to sow seeds of success in Africa

29 Jul 2022

Optimized pyridazinone nutrient channel inhibitors are potent and specific antimalarial leads

07 Jul 2022

Clinical and population-based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy

01 Jul 2022
All publications

Events

13
Sep

Malaria in Pregnancy Working Group Annual Meeting

September 13 - 15, 2022
Accra, Ghana
All events

Films

World Malaria Day 2022 videos

25 Apr 2022

International Day of the Girl Child 2021

11 Oct 2021

Opt-SMC: optimizing access to medicines to protect children from malaria

14 Jul 2020
All films

Interviews

Accelerating open drug discovery

Dr Kirandeep Samby, MMV Open project leader
07 Jul 2022

Brazil: the first real-world use of new protocol for P. vivax case management

Representatives of the Brazilian Ministry of Health and Dr Dhelio Pereira, Director of Clinical Research at the Tropical Medicine Research Center of Rondonia (CEPEM) discuss the results of Phase I of TRuST and the next steps
07 Jul 2022

Studying pyronaridine-artesunate: an important addition to the malaria toolbox

Prof. Francine Ntoumi, Executive Director, Congolese Foundation for Medical Research (FCRM), CANTAM Coordinator
07 Jul 2022

A compound with the potential to resist drug resistance

Dr Cornelis Winnips, Global Program Clinical Head, and Dr Anne Claire Marrast, Senior Medical Director, Novartis
06 Jul 2022
All interviews

Slideshows

On Okello’s trail: a day in the life of a malaria health worker

27 Aug 2021

World Mosquito Day 2021

19 Aug 2021

Molecules making a difference

15 Jan 2021
All slideshows
  • RSS subscribe
    Printer friendly

Follow us

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Subscribe

Previous newsletters

Contact us

  • Tel: +41 22 555 03 00

    • Message us
    • Office directions
© MMV 2022
Website by Manta Ray Media
  • Glossary
  • Disclaimer
  • Privacy
  • Sitemap